Ramsay Stattman Vela & Price’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $784K | Sell |
8,666
-330
| -4% | -$30.3K | 0.15% | 62 |
|
|
2025
Q4 | $809K | Sell |
8,996
-205
| -2% | -$19.4K | 0.15% | 63 |
|
|
2025
Q3 | $906K | Sell |
9,201
-325
| -3% | -$32.2K | 0.16% | 61 |
|
|
2025
Q2 | $869K | Sell |
9,526
-705
| -7% | -$68.2K | 0.16% | 61 |
|
|
2025
Q1 | $1.16M | Sell |
10,231
-808
| -7% | -$86.4K | 0.22% | 60 |
|
|
2024
Q4 | $1.17M | Sell |
11,039
-190
| -2% | -$20.4K | 0.22% | 59 |
|
|
2024
Q3 | $1.21M | Sell |
11,229
-965
| -8% | -$105K | 0.23% | 57 |
|
|
2024
Q2 | $1.32M | Buy |
12,194
+63
| +0.5% | +$7.43K | 0.25% | 55 |
|
|
2024
Q1 | $1.6M | Sell |
12,131
-40
| -0.3% | -$5K | 0.31% | 53 |
|
|
2023
Q4 | $1.48M | Buy |
12,171
+73
| +0.6% | +$8.15K | 0.3% | 54 |
|
|
2023
Q3 | $1.36M | Sell |
12,098
-570
| -4% | -$72.4K | 0.29% | 56 |
|
|
2023
Q2 | $1.84M | Sell |
12,668
-147
| -1% | -$20K | 0.38% | 53 |
|
|
2023
Q1 | $1.66M | Sell |
12,815
-3,430
| -21% | -$431K | 0.36% | 56 |
|
|
2022
Q4 | $2.07M | Sell |
16,245
-10,700
| -40% | -$1.24M | 0.47% | 50 |
|
|
2022
Q3 | $2.82M | Sell |
26,945
-280
| -1% | -$30.7K | 0.7% | 41 |
|
|
2022
Q2 | $2.86M | Sell |
27,225
-1,410
| -5% | -$167K | 0.64% | 42 |
|
|
2022
Q1 | $3.66M | Sell |
28,635
-2,090
| -7% | -$252K | 0.71% | 41 |
|
|
2021
Q4 | $3.79M | Sell |
30,725
-834
| -3% | -$109K | 0.86% | 35 |
|
|
2021
Q3 | $4.48M | Sell |
31,559
-927
| -3% | -$136K | 1.12% | 34 |
|
|
2021
Q2 | $5.07M | Sell |
32,486
-4,110
| -11% | -$666K | 1.25% | 32 |
|
|
2021
Q1 | $5.69M | Sell |
36,596
-165
| -0.4% | -$25.6K | 1.51% | 30 |
|
|
2020
Q4 | $5.5M | Sell |
36,761
-31
| -0.1% | -$4.38K | 1.54% | 30 |
|
|
2020
Q3 | $4.86M | Buy |
36,792
+345
| +0.9% | +$45.1K | 1.51% | 30 |
|
|
2020
Q2 | $4.22M | Sell |
36,447
-602
| -2% | -$69.4K | 1.46% | 30 |
|
|
2020
Q1 | $3.64M | Sell |
37,049
-211
| -0.6% | -$27.7K | 1.43% | 31 |
|
|
2019
Q4 | $5.42M | Buy |
37,260
+10
| +0% | +$1.38K | 1.73% | 30 |
|
|
2019
Q3 | $4.96M | Buy |
37,250
+113
| +0.3% | +$14.6K | 1.72% | 31 |
|
|
2019
Q2 | $4.25M | Sell |
37,137
-1,328
| -3% | -$156K | 1.52% | 33 |
|
|
2019
Q1 | $4.77M | Buy |
38,465
+988
| +3% | +$112K | 1.74% | 32 |
|
|
2018
Q4 | $3.77M | Buy |
37,477
+78
| +0.2% | +$8.77K | 1.57% | 33 |
|
|
2018
Q3 | $4.77M | Buy |
37,399
+412
| +1% | +$49K | 1.74% | 31 |
|
|
2018
Q2 | $4M | Buy |
36,987
+221
| +0.6% | +$24.1K | 1.59% | 31 |
|
|
2018
Q1 | $3.89M | Buy |
36,766
+2,951
| +9% | +$343K | 1.58% | 31 |
|
|
2017
Q4 | $3.96M | Sell |
33,815
-1,061
| -3% | -$120K | 1.57% | 31 |
|
|
2017
Q3 | $3.96M | Buy |
34,876
+999
| +3% | +$115K | 1.67% | 31 |
|
|
2017
Q2 | $4.22M | Buy |
33,877
+101
| +0.3% | +$12K | 1.84% | 29 |
|
|
2017
Q1 | $4M | Buy |
33,776
+43
| +0.1% | +$4.87K | 1.83% | 29 |
|
|
2016
Q4 | $3.38M | Buy |
33,733
+1,757
| +5% | +$188K | 1.6% | 31 |
|
|
2016
Q3 | $4.04M | Buy |
31,976
+221
| +0.7% | +$27.3K | 1.93% | 30 |
|
|
2016
Q2 | $3.71M | Buy |
31,755
+2,333
| +8% | +$264K | 1.83% | 30 |
|
|
2016
Q1 | $3.05M | Buy |
29,422
+160
| +0.5% | +$15.5K | 1.57% | 30 |
|
|
2015
Q4 | $2.92M | Buy |
+29,262
| New | +$2.86M | 1.46% | 31 |
|
Other funds holding ZBH
VCM
VPM
Ramsay Stattman Vela & Price's ZBH Position: Q1 2026 in Review
Ramsay Stattman Vela & Price reduced its Zimmer Biomet (ZBH) stake by 3.7% in Q1 2026, selling an estimated $30.3K and leaving 8,666 shares worth $784K. The position accounts for 0.15% of the portfolio, ranked #62.
Ramsay Stattman Vela & Price first reported a position in ZBH in Q4 2015 and has held it in 42 quarters since. The position peaked at $5.69M in Q1 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Ramsay Stattman Vela & Price held 8,666 shares of Zimmer Biomet worth $784K as of Q1 2026.
- Ramsay Stattman Vela & Price sold 330 Zimmer Biomet shares in Q1 2026, an estimated $30.3K.
- Zimmer Biomet made up 0.15% of Ramsay Stattman Vela & Price's portfolio in Q1 2026, its #62 holding.
- Ramsay Stattman Vela & Price first reported a position in Zimmer Biomet in Q4 2015 and has held it in 42 quarters since.
- Ramsay Stattman Vela & Price's Zimmer Biomet position peaked at $5.69M in Q1 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Ramsay Stattman Vela & Price's 13F filing for Q1 2026, filed 30 Apr 2026.